GLP1R and type 2 diabetes mellitus: Fasting plasma glucose and HbA1c reductions were reduced with once-weekly GLP-1 medication [24]. GLP-1 seems to be a better option for the reduction of HbA1c among patients with uncontrolled T2DM than other novel medications such as DPP-4i and SGLT-2i [24].